The prevention, diagnosis, and management of infectious disease in transplantation are
major contributors to improved outcomes in organ transplantation. The risk of serious …

Post-Transplantation Lymphoproliferative Disorders Solid-organ and hematopoietic stem-
cell transplants are widely used for various life-threatening medical disorders. Prophylaxis …

These updated guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice review the diagnosis, management, and prevention of post …

Successful solid organ transplantation reflects meticulous attention to the details of
immunosuppression, balancing risks for graft rejection against risks for infection. The “net …

Cancer is the second most common cause of mortality and morbidity in kidney transplant
recipients after cardiovascular disease. Kidney transplant recipients have at least a twofold …

Post-transplant lymphoproliferative diseases (PTLD) are heterogeneous lymphoid disorders
ranging from indolent polyclonal proliferations to aggressive lymphomas that complicate …

Background Post-transplantation lymphoproliferative disorder (PTLD) develops in 1–10% of
transplant recipients and can be Epstein–Barr virus (EBV) associated. To improve long-term …

Epstein–Barr virus (EBV) is an important pathogen in recipients of solid organ transplants
(SOT). Infection with EBV manifests as a spectrum of diseases/malignancies ranging from …

Allogeneic hematopoietic stem cell transplantation is a successful treatment for hematologic
malignancies and a variety of genetic and metabolic disorders. In the period following stem …

We examined the associations of Epstein–Barr virus (EBV) status with characteristics and
outcomes of posttransplantation lymphoproliferative disorder (PTLD) by studying 176 adult …